1                                                             We compared the number of abnormal test locations at the 5% l

2                                                             We compared the number of CAG repeats, the age at death, and

3                                                             We compared the number of eyes with detected DH at any time d

4                                                             We compared the number of first and senior author publication

5                                                             We compared the number of infections identified with the numb

6                                                             We compared the number of people and their physical activity

7                                                             We compared the numbers of breast cancers among the 214 high-

8                                                             We compared the numbers of cases of GBS observed immediately

9 th certificates in the United States between 1973 and 1988, we compared the number of deaths in the first week of the mon

10                    By measuring whole-cell current density, we compared the number of functional channels in WT- and Delt

11                                                      First, we compared the number of C(alpha)-H cdots, three dots, cente

12 e neural responses to sexual behavior in females and males, we compared the number of Fos-like immunoreactive (Fos-ir) ne

13                                 To estimate relative risks, we compared the number of observed breast cancers with the nu

14   To evaluate whether the uncertainty principle was upheld, we compared the number of studies favouring experimental trea

15                                           In addition, when we compared the number of matched peptides and the percentage

16 In a quasi-experimental study in Christchurch, New Zealand, we compared the number of cases of Legionnaires' disease requ